BioFortis
Gentris has selected BioFortis' Labmatrix and Qiagram software to manage samples and data collection and integration activities in its biorepository.
France Funds $17M Cancer Profiling, Biomarker Effort
NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.
OpenEye has released AFITT 2.2.0, an application designed to help crystallographers fit ligands to observed data.
BioFortis said the foundation will use the platform to collect and manage patient specimen data and clinical information, track shipment status, analyze data from thousands of patient biospecimens, and view real-time study results from pre-built or ad hoc data queries.
Investigators at Rush University Medical Center will use BioFortis' Labmatrix to manage its biobank and biomarker data for research efforts focused on early detection and diagnosis of cancer and neurodegenerative diseases.
Sep 10, 2010